Protara Therapeutics (TARA) Receivables - Other (2014 - 2019)
Protara Therapeutics (TARA) posted quarterly Receivables - Other of -$7000.0 for Q4 2019, up 86.54% year-over-year from -$3752.6 in Q4 2018, and down 40.0% quarter-over-quarter from -$5000.0 in Q3 2019.
Powered by 
Analysis
Protara Therapeutics (TARA) Receivables - Other (2014 - 2019) Analysis & Trends
Protara Therapeutics (TARA) has reported Receivables - Other for 6 consecutive years, with -$7000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Receivables - Other rose 86.54% year-over-year to -$7000.0; the TTM figure through Dec 2019 stood at -$17000.0 (up 65.31% YoY), while the FY2019 annual figure was -$17000.0, up 65.31% from the prior year.
- Receivables - Other eased to -$7000.0 in Q4 2019 per TARA's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $305000.0 in Q1 2015 and bottomed at -$182000.0 in Q4 2015.
- Historically, Receivables - Other has averaged $2111.1 across 5 years, with a median of -$3500.0 in 2017.
- On a YoY basis, Receivables - Other climbed as much as 2133.33% in 2015 and fell as far as 768.75% in 2015.
- Protara Therapeutics' Receivables - Other stood at -$182000.0 in 2015, then soared by 139.56% to $72000.0 in 2016, then slumped by 137.5% to -$27000.0 in 2017, then sank by 92.59% to -$52000.0 in 2018, then soared by 86.54% to -$7000.0 in 2019.
- Business Quant data shows TARA's Receivables - Other at -$7000.0 in Q4 2019, -$5000.0 in Q3 2019, and -$20000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | -7,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Jun 30, 2017 | -3,000.00 |
| Mar 31, 2017 | 15,000.00 |
| Dec 31, 2016 | 72,000.00 |
| Sep 30, 2016 | -72,000.00 |
| Mar 31, 2016 | 26,000.00 |
| Dec 31, 2015 | -182,000.00 |
| Sep 30, 2015 | 16,000.00 |
| Jun 30, 2015 | -107,000.00 |
| Mar 31, 2015 | 305,000.00 |
| Sep 30, 2014 | 12,000.00 |
| Jun 30, 2014 | 16,000.00 |